Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer

By sjmartinez • December 10, 2024

Truong A, Liu J, Ni C, Yashar S. Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer. JAAD Case Rep. 2024 Oct 28;54:62-65. doi: 10.1016/j.jdcr.2024.10.007. PMID: 39654848; PMCID: PMC11626054.

Tags: adverse reaction, chilblain lupus, cutaneous lupus, Dermatology, Drug reaction, erdafitinib, oncodermatology, Publications, Resident, side effect, targeted therapy, Veterans Administration

International development of Investigator Global Assessment scores for pemphigus

Murrell DF, Boucher D, Daneshpazhooh M, Mahmoudi H, Kianfar N, Dasdar S, Yale M, Wilson A, Bilgic A, Uzun S, Chandran NS, Patsatsi A, Drenovska[...]

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]

Incubating Artificial Intelligence (AI) Initiatives and Careers in Dermatology

Wongvibulsin S, Primiero CA, Adamson AS, Barata C, Betz-Stablein B, Celebi ME, Dawant B, Guitera P, Kelly KM, Kittler H, Kose K, Landman B, Lehman[...]